Keyword: insulin

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

As FDA commissioner, Scott Gottlieb battled to lower the cost of prescription drugs. Now, Gottlieb is taking that fight to the private sector.

A new bill to legalize insulin imports comes amid a congressional probe of pricing directed at insulin makers Sanofi, Novo Nordisk and Eli Lilly.

The U.S. estimates that close to 1 million people in California cross to Mexico annually for healthcare.

Already under pressure from lawsuits and Congress for its insulin pricing, Eli Lilly faces a pair of new state-level investigations.

Eli Lilly's answer to rival Novo Nordisk's price-increase promises? A similar—though somewhat less potent—pledge. 

Novo Nordisk has seen its position in the Chinese diabetes market whittled away in the last couple of years, but it says new products will keep it on top.

Researchers at Texas A&M University have developed a nano-sized delivery system that could help bring injected treatments such as insulin into the oral realm, making the regimen easier on the patient and clinician.

A new study from Washington University has shown that stem cells programmed to act like insulin-secreting beta cells could give Type 1 diabetes patients the treatment they need.